United Ciigma Institute Of Medical Sciences Profile
Key Indicators
- Authorised Capital ₹ 52.00 Cr
- Paid Up Capital ₹ 51.37 Cr
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 140.00 Cr
- Satisfied Charges ₹ 400.96 Cr
- Revenue Growth 4.34%
- Profit Growth -29.58%
- Ebitda -14.57%
- Net Worth 337.04%
- Total Assets 41.43%
About United Ciigma Institute Of Medical Sciences
United Ciigma Institute Of Medical Sciences Private Limited (UCIOMSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 07 February 2011 and has a history of 13 years and 11 months. Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 52.00 Cr and a paid-up capital of Rs 51.37 Cr.
The company currently has active open charges totaling ₹140.00 Cr. The company has closed loans amounting to ₹400.96 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at United Ciigma Institute Of Medical Sciences Private Limited India are Divyanki Sharma as COMPANY SECRETARY and Anand Venugopal as Cfo. Kewal Handa, Manisha Takalkar, Ekta Bahl, and Five other members serve as directors at the Company.
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74120MH2011PTC213136
- Company No.
213136
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Feb 2011
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at United Ciigma Institute Of Medical Sciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Unmesh Takalkar  | Managing Director | 07-Feb-2011 | Current |
| Divyanki Sharma | Company Secretary | 08-Jan-2024 | Current |
| Anand Venugopal | CFO | 08-Jan-2024 | Current |
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Varun Khanna | Additional Director | 28-Jun-2024 | Current |
| Mahadevan Narayanamoni | Director | 26-Jul-2022 | Current |
| Jasdeep Singh | Director | 26-Jul-2022 | Current |
| Ekta Bahl | Director | 20-Jan-2023 | Current |
| Kewal Handa | Director | 23-Mar-2023 | Current |
| Manisha Takalkar | Director | 07-Feb-2011 | Current |
Financial Performance of United Ciigma Institute Of Medical Sciences.
United Ciigma Institute Of Medical Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.34% increase. The company also saw a substantial fall in profitability, with a 29.58% decrease in profit. The company's net worth Soared by an impressive increase of 337.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of United Ciigma Institute Of Medical Sciences?
In 2023, United Ciigma Institute Of Medical Sciences had a promoter holding of 99.30% and a public holding of 0.70%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Wellness Forever Medicare LimitedKewal Handa is a mutual person
Salus Lifecare Private LimitedKewal Handa is a mutual person
Omsav Pharma Research Private LimitedKewal Handa is a mutual person
_PRIVATE_LIMITED.webp)
International Gemmological Institute (India) LimitedTejas Naphade is a mutual person
Infiiloom India Private LimitedKewal Handa is a mutual person
Poonawalla Fincorp LimitedKewal Handa is a mutual person
Charges (Loans)
₹140.00 Cr
₹400.96 Cr
Charges Breakdown by Lending Institutions
- Idbi Trusteeship Services Limited : 140.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Nov 2018 | Idbi Trusteeship Services Limited | ₹140.00 Cr | Open |
| 18 Feb 2022 | Idbi Trusteeship Services Limited | ₹10.50 Cr | Satisfied |
| 20 Mar 2021 | Idbi Trusteeship Services Limited | ₹21.00 Cr | Satisfied |
| 29 Jan 2021 | Others | ₹1.26 Cr | Satisfied |
| 30 Jun 2020 | Others | ₹8.00 Cr | Satisfied |
How Many Employees Work at United Ciigma Institute Of Medical Sciences?
United Ciigma Institute Of Medical Sciences has a workforce of 73 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of United Ciigma Institute Of Medical Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped United Ciigma Institute Of Medical Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
